Medication adherence and its effect on relapse among patients discharged from a Veterans Affairs Posttraumatic Stress Disorder Treatment Program

Annals of Pharmacotherapy

Volumn 43, Issue 7-8, 2009, Pages 1227-1232

  Lockwood, Anna ^a   Steinke, Douglas T ^b   Botts, Sheila R ^b  

^a LEXINGTON VA MEDICAL CENTER   (United States)

^b University of Kentucky   (United States)

Author keywords

Medication adherence; Medication persistence; Medication possession ratio; Posttraumatic stress disorder

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL FEATURE; COMORBIDITY; HEALTH PROGRAM; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL SERVICE; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VETERAN;

ADULT; ANTIDEPRESSIVE AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT READMISSION; RECURRENCE; RESIDENTIAL TREATMENT; RETROSPECTIVE STUDIES; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS;

EID: 67651087332     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M017     Document Type: Article

References (23)

1. Overview of posttraumatic stress disorder. http://uptodateonline.com/utd/ content/topic.do?topicKey=psychiat/6279&selectedTitle=1~50&source= search-result (accessed 2007 Sept 25).
2. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-1060
3. Breslau N, Davis GC, Andreski P, Peterson E. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 1991;48:216-222
4. Resnick HS, Kilpatrick DG, Dansky BS, et al. Prevalence of civilian trauma and posttraumatic stress disorder in a representative national sample of women. J Gen Intern Med 1993;61:984-991
5. Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 2004;351:13-22. (Pubitemid 38857243)
6. Rapaport MH, Endicott J, Clary CM. Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment. J Clin Psychiatry 2002;63:59-65. (Pubitemid 34113489)
7. www.oqp.med.va.gov/cpg/PTSD/PTSD-cpg/frameset.htm (accessed 2008 Jul 23).
8. Shalev AY, Friedman MJ, Foa EB, et al. Integration and summary. In: Foa EB, Keane TM, Friedman MJ. Effective treatments for PTSD: practice guidelines from the International Society for Traumatic Stress Studies. New York: Guilford Press, 2000:359-379
9. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998;55:1128-1132 (Pubitemid 28558286)
10. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497
11. Cramer J, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998;49:196-201. (Pubitemid 28071427)
12. Maddox JC, Levi M, Thompson C. The compliance with antidepressants in general practice. J Psychopharmacol 1994;8:48-52.
13. Spoont M, Sayer N, Nelson DB. PTSD and treatment adherence: the role of health beliefs. J Nerv Ment Dis 2005;193:515-522 (Pubitemid 41140938)
14. American Psychiatric Association. Practice guidelines for the treatment of patients with acute stress disorder and posttraumatic stress disorder. www.psychiatryonline.com/content.aspx?aID=52967. DOI 10.1176/appi.books. 9780890423363.52257 (accessed 2009 Apr 2).
15. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther 2005;27:1064-1073
16. Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2006;1:CD002795. www.cochrane.org/reviews/en/ab002795.html (accessed 2009 Apr 2). (Pubitemid 46841286)
17. Davidson JRT, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of post-traumatic stress disorder. Arch Gen Psychiatry 2001;58:485-492 (Pubitemid 32411330)
18. VA/DoD clinical practice guidelines: post traumatic stress disorder. www.oqp.med.va.gov/cpg/PTSD/PTSD-Base.htm (accessed 2008 Jul 23).
19. Cramer JA, Benedict A, Muszbec N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension, and dyslipidemia: a review. Int J Clin Pract 2008;62:76-87. (Pubitemid 350294021)
20. Jancin B. Pill burden influences patient adherence to heart drugs. Internal Medicine News 2006;39:50.
21. Bangsberg DR, Wu Y, Yuan Y, Iloeje U. Pill burden predicts adherence, regimen discontinuation or switch, viral load and CD4 cell response in a nationwide US sample of HIV+ antiretroviral naïve people on protease inhibitor (PI) therapy. Antiviral Therapy 2003;8. retrieved April 2009 from the National Library of Medicine. http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f= 102263036.html (accessed 2009 Apr 2).
22. Brookhart MA, Patrick AR, Schneeweiss S, et al. Physician follow up and provider continuity are associated with long-term medication adherence. Arch Intern Med 2007;167:847-852
23. Murdoch M, Halek K, Fortier L, van Ryn M, Hodges J. Service connection for posttraumatic stress disorder (PTSD) disability benefits depend on race and region but not on gender (abstract). Health Services Research 2001;18:17. Abstract retrieved April 2009 from the National Library of Medicine. http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102273210.html (accessed 2009 Apr 2).